Acta Neurol Scand. 1992 Oct;86(4):371-5.

Treatment of myotonia with antiarrhythmic drugs.

Source

Department of Neurology, Warsaw Medical Academy, Poland.

Abstract

The effects of disopyramide, phenytoin, mexiletine, and tocainide were compared in 30 patients with myotonic disorders. The severity of myotonia was assessed by clinical and electromyographic criteria at the end of each treatment phase lasting four weeks. Mexiletine (MXT) and tocainide (TCD) were found to be the most potent antimyotonic agents. The antimyotonic efficacy of MXT and TCD is explained by their fast-blocking effect on voltage-dependent sodium channels in the muscle membrane. The benefits of myotonia control with pharmacological agents must be weight against the risk of therapy in the individual patient. Because of the risks of hematologic problems, TCD is not recommended by us for the treatment of myotonia.

PMID:: 1455983; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Molecular Biology Databases

PHENYTOIN SODIUM - HSDB

Supplemental Content

Save items

Related citations in PubMed

Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert. [J Neurol. 1985]
Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert.
Mielke U, Haass A, Sen S, Schmidt W. J Neurol. 1985; 232(5):271-4.
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse. [Neuromuscul Disord. 2004]
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
De Luca A, Pierno S, Liantonio A, Desaphy JF, Natuzzi F, Didonna MP, Ferrannini E, Jockusch H, Franchini C, Lentini G, et al. Neuromuscul Disord. 2004 Jul; 14(7):405-16.
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. [Neurology. 2010]
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Logigian EL, Martens WB, Moxley RT 4th, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, et al. Neurology. 2010 May 4; 74(18):1441-8.
Review Drug treatment for myotonia. [Cochrane Database Syst Rev. 2006]
Review Drug treatment for myotonia.
Trip J, Drost G, van Engelen BG, Faber CG. Cochrane Database Syst Rev. 2006 Jan 25; (1):CD004762. Epub 2006 Jan 25.
Review New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil. [Am J Cardiol. 1978]
Review New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil.
Zipes DP, Troup PJ. Am J Cardiol. 1978 May 22; 41(6):1005-24.

See reviews... See all...

Cited by 5 PubMed Central articles

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. [Neurology. 2010]
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Logigian EL, Martens WB, Moxley RT 4th, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, et al. Neurology. 2010 May 4; 74(18):1441-8.
Review Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre. [Acta Myol. 2008]
Review Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.
Lehmann-Horn F, Jurkat-Rott K, Rüdel R, Ulm Muscle Centre. Acta Myol. 2008 Dec; 27:98-113.
Case 12: my doctor says that I have ALS! [MedGenMed. 2006]
Case 12: my doctor says that I have ALS!
Wilson RK, Chaudhry V. MedGenMed. 2006 Mar 22; 8(1):76. Epub 2006 Mar 22.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of myotonia with antiarrhythmic drugs.
Treatment of myotonia with antiarrhythmic drugs.
Acta Neurol Scand. 1992 Oct ;86(4):371-5.

PubMed
PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in a...
PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Cancer Res. 2003 Oct 1 ;63(19):6357-62.

PubMed
Depression in the early phase of MS: influence of functional disability, cogniti...
Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalities.
Acta Neurol Scand. 1992 Oct ;86(4):354-8.

PubMed
Reconciling gene expression data with known genome-scale regulatory network stru...
Reconciling gene expression data with known genome-scale regulatory network structures.
Genome Res. 2003 Nov ;13(11):2423-34. Epub 2003 Oct 14 .

PubMed
Driving performance in cold, warm, and thermoneutral environments.
Driving performance in cold, warm, and thermoneutral environments.
Appl Ergon. 2003 Nov ;34(6):597-602.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Treatment of myotonia with antiarrhythmic drugs.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 5 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information